A new dust testing methodology developed by University of Queensland researchers offers workers better protection from diseases such as black lung and silicosis.
Vertex, U.K. reach deal to provide CRISPR-based medicine to thalassemia patients in England
LONDON — Patients in England with a rare blood disorder will now be able to receive the world’s first CRISPR-based medicine, after drugmaker Vertex Pharmaceuticals